Sapheon raised $3.6 million of a hoped-for $10 million in a convertible debt offering it plans to use as working capital, according to a regulatory filing.
Forty-nine unnamed investors participated in the round for Morrisville, N.C.-based Sapheon, which makes the VenaSeal device for treating varicose veins, according to the filing.